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ANALYSIS
Chronic disease is the great epidemic of our 
times, but the strategies we have developed 
to manage it have created a growing burden 
for patients. This treatment burden induces 
poor adherence, wasted resources, and poor 
outcomes. Against this background, we call 
for minimally disruptive medicine that seeks 
to tailor treatment regimens to the realities of 
the daily lives of patients. Such an approach 
could greatly improve the care and quality of 
life for patients.
Non-adherence, culpability, and 
susceptibility
Poor adherence to medical advice and drug 
regimens is a global problem with a long his-
tory. Non-adherence is important because 
many therapeutic interventions are effective 
only if used correctly, which requires continu-
ous personal investment of time and effort 
from patients. The epidemiological transi-
tion from acute diseases, where the emphasis 
was on cure, to chronic illnesses that instead 
require management also means that patients 
take on a lifetime burden. Poor adherence 
can lead to complications in professional-
patient relationships, additional ill health and 
expenditure for patients and their families, 
and the waste or misallocation of healthcare 
resources.1-3
The aetiology of non-adherence is com-
plex, but individual culpability has been 
assumed to play an important part.4 5 People 
with chronic (and other) illnesses who do not 
adhere to treatment generally say that they 
recognise that they ought to do otherwise 
but that they lack the capacity, skills, and 
understanding to do so. In one study, 45% 
of patients gave such reasons for intention-
ally not adhering to treatment for chronic 
illnesses.6 Recent research on adherence has 
focused, therefore, on interventions. The aim 
of these interventions is twofold: to improve 
patient uptake of treatments by giving them 
tools to share in understanding the relevance 
and importance of certain behaviours and 
treatments; and to encourage them to “buy 
in” to those behaviours and enhance their 
ownership of therapeutic regimens. Much 
of the research has been done in the context 
of randomised controlled trials of treatments 
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Thus our understanding of adherence is of 
limited applicability to usual care.3 7- 9
Chronic illness and chronic workload
Studies that examine adherence often 
exclude two large groups of patients that 
health professionals encounter in real life: 
people who have diminished capacity to 
cope with therapeutic regimens because of 
cognitive impairment and people with mul-
tiple chronic comorbidities. Both groups 
often present complex social problems that 
are related to their illness and confound 
treatment.10 Perhaps more than 60% of 
older people have multiple chronic condi-
tions, representing an increasing propor-
tion of people who need health care.11 12 
The burden of chronic illness falls not only 
on health services but also on patients and 
carers, as the work of managing chronic 
disease increasingly shifts from the clinic 
to the home. They must cope with increas-
ingly complex treatment regimens and work 
to normalise these in their daily lives (see 
example 1 in box).13
Other factors exacerbate this situation. 
Treatment burdens are often imposed on 
patients with little coordination between, 
or even within, clinics dealing with differ-
ent conditions and little explicit recognition 
that treatment regimens are demanding in 
time and effort. In addition, evidence based 
guidelines provide disease specific guid-
ance for doctors but often fail to acknowl-
edge multiple morbidities as management 
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problems. Fractured care means that such 
patients often receive care from several 
different clinicians, whose uncoordinated 
prescriptions and recommendations lead to 
polypharmacy, increased treatment costs, 
side effects, and unintended drug interac-
tions. Patients are thus overwhelmed not 
just by the burden of illness, but by the ever 
present and expanding burden of treatment 
(see examples 2 and 3 in box). 
The work of being a patient includes much 
more than drug management and self moni-
toring. It also includes organising doctors’ 
visits and laboratory tests. Patients may also 
need to take on the organisational work of 
passing basic information about their care 
between different healthcare providers and 
professionals. In some countries, they must 
also take on the contending demands of 
insurance and welfare agencies. This means 
that although intensifying treatment often 
seems the solution to the patient’s problems, 
it adds to them (see example 4). Advances in 
diagnosis and treatment thus have the para-
doxical effect of adding incrementally to the 
work of being sick. Patients who cannot cope 
eventually experience iatrogenic outcomes 
and poorer quality of life, just as surely as 
do those who are affected by medical acci-
dents or errors. Clinicians cannot respond 
adequately to this problem. They lack the 
tools to detect patients overwhelmed by the 
burdens of treatment, and they lack strate-
gies to lift these burdens.
Four principles for minimally disruptive 
medicine
We have highlighted two problems in the 
care of people with chronic conditions: 
non-adherence with treatment and unco-
ordinated and increasing 
workload. These prob-
lems have important con-
nections. We propose that 
some non-adherence is 
structurally induced by 
the healthcare system. 
Our diagnosis of the overburdened patient 
suggests that complex, chronic, comorbidi-
ties have their counterparts in problems of 
healthcare systems themselves.
Are there solutions to these structurally 
induced problems? Solving them will be a 
long haul. But we can make a start by apply-
ing four principles to guide health services 
design and clinical research questions.
Establish the weight of burden—Clinicians 
and researchers need reliable tools to iden-
tify overburdened patients and those with 
capacity problems, such as poor recall or 
comprehension of instructions or difficulties 
in administering their treatment. These tools 
must describe treatment burden across indi-
viduals requiring similar treatment, taking 
into account patient values and preferences 
as well as the effects of multiple comorbid-
ity and social circumstances—asking, what is 
the effective yet least burdensome treatment 
programme for this person with this set of 
conditions in this context? They would also 
describe treatment burden within the same 
individual over time. Healthcare providers 
also need reliable tools to understand so called 
non-adherence as a problem that can be struc-
turally induced at a system level by their own 
beliefs, preferences, and behaviours.
Encourage coordination in clinical practice—
The role of primary care doctors in manag-
ing chronic disease has been an important 
focus of policy debates on both sides of the 
Atlantic.14 Primary care has traditionally 
sought to coordinate care for people with 
multiple morbidities. However, incentives 
have been used mainly to improve outcomes 
in specific diseases (such as asthma, diabetes) 
rather than to manage complexity and comor-
bidity. For example, the new general medical 
services contract in the UK offers incentives 
to meet key clinical targets for individual 
chronic diseases. Incentives should instead 
prioritise holistic approaches and improved 
coordination of care.15
Acknowledge comorbidity in clinical evidence—
Incentives to improve disease specific 
outcomes rely on an evidence base that 
focuses on disease specific processes. The 
effects of complexity and comorbidity are 
systematically excluded from most practice 
guidelines.16 Improved coordination of care 
depends on the improved coordination of 
clinical knowledge, and the development 
of robust techniques for 
translating this into clinical 
guidelines that deal explic-
itly with the problems of 
managing multiple chronic 
conditions. Even though 
the permutations of comor-
bidity are a problem, such guidelines could 
cover chronic conditions that commonly 
coexist, such as diabetes, coronary heart dis-
ease, heart failure, and chronic obstructive 
pulmonary disease.
Prioritise from the patient perspective—Patients 
have a role in improving the coordination of 
their care, and this extends beyond adminis-
trative work on behalf of a health provider. 
A core assumption of principles of patient 
autonomy and shared decision making, and 
a constant feature of research on experiences 
of sick people, is that they are able to make 
meaningful choices about the interactions 
between their illnesses and clinical interven-
tions.17 Since only patients and their caregiv-
ers can report on the burden of treatment, 
they should participate in deciding which 
conditions to tackle next and to what extent. 
Given the evidence for efficacy and the bur-
den of treatment involved, an asymptomatic 
patient with diabetes, for example, may 
Clinicians lack the tools to 
detect patients overwhelmed  
by the burdens of treatment, 
and they lack strategies to  
lift these burdens
Patient burden of health care 
Example 1—A man being treated for heart failure in UK primary care rejected the offer to attend a 
specialist heart failure clinic to optimise management of his condition. He stated that in the previous 
two years he had made 54 visits to specialist clinics for consultant appointments, diagnostic tests, and 
treatment. The equivalent of one full day every two weeks was devoted to this work.
Example 2—In the US, a woman in her late 70s was under medical evaluation for possible placement 
in a nursing home because of “inability to care for herself.” Detailed questioning revealed that she was 
taking medications at 11 separate times during the day, which was very disruptive of her life, especially as 
some of these doses were linked to food ingestion. None of her doctors was aware of this behaviour. The 
pharmacist was able to consolidate and schedule the medicines around the woman’s activities into a three 
times daily administration. She continues to live independently.
Example 3—In the UK, a man in his late 70s with heart failure talked of the effort required to adhere to a 
complex drug regimen: “I’ve got a book and I note everything down. I note the time, the drug, and when 
I’ve taken it. When you are doing activities throughout the house or you are otherwise engaged you can 
quite easily forget to take them and sometimes you don’t really know whether you’ve taken them or 
not—that can happen, its surprising. So I make a point of noting down the drug I take and the time I take it 
and I tick it off. So if I think that I haven’t done it, I have a look and if I haven’t ticked it off and noted down I 
assume I haven’t taken it. You have to be careful, particularly with the warfarin. They are very keen on you 
maintaining your dose.”
Example 4—In the US, a primary care doctor referred a man in his 50s with type 2 diabetes and a raised 
glycated haemoglobin concentration to an endocrinologist after noting insufficient glycaemic control 
with maximum doses of metformin and glipizide. The endocrinologist added pioglitazone and maximised 
the dose with no response. Similar failure accompanied the use of exenatide. A year after starting to 
see the endocrinologist the patient’s HbA1c concentration was even higher. When the endocrinologist 
offered glargine insulin instead, the patient complained that the drugs were too expensive. A review of 
his pharmacy records indicated that the patient had never collected the prescriptions for pioglitazone or 
exenatide because of their cost.
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prefer to approach lipid and blood pressure 
control before seeking to control glycaemia. 
Patient involvement must be a central part of 
disentangling individual and collective treat-
ment burdens.
Together these principles may inform pol-
icy and practice that enhance clinical and 
cost effectiveness, and at the same time be 
easier, safer, and less costly for patients to 
enact in their own lives. They also offer an 
opportunity to reinvigorate  and re-empha-
sise the importance of the generalist role of 
the primary care doctor at a time when—in 
the UK, at least—there is increased emphasis 
on disease specific targeting and much rou-
tine chronic disease surveillance and man-
agement is delegated to nurses or patients. 
The principles have important implications 
for the relation between research and prac-
tice. Here, health services research, the social 
sciences, clinical medicine, and the basic sci-
ences of therapeutics can interact with each 
other in new ways. This is because solutions 
to the problems we identify need to address 
highly complex systems rather than individ-
ual pathological processes. In such a context, 
polypills—which are such contentious solu-
tions to public health problems—become 
suitable approaches to complex comorbidi-
ties in clinical medicine. Such approaches 
have recently been shown to make important 
contributions to improved patient outcomes 
in the management of HIV and AIDS.18
Conclusion
We need to think more about the burdens of 
treatment. These are different from the bur-
dens of illness. This becomes more urgent in 
the light of the policy emphasis on self care 
and what we know about its effects.19 More 
fundamentally, thinking seriously about the 
burden of treatment may help us begin to 
think about minimally disruptive medicine—
forms of effective treatment and service pro-
vision that are designed to reduce the burden 
of treatment on their users.
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PICTURE QUIz
An unusual case of  
haemorrhagic stroke
1  The head computed tomogram shows a 
subarachnoid haemorrhage in the left sylvian 
fissure and overlying convexity.
2  The most common causes of non-traumatic 
subarachnoid haemorrhage are ruptured 
intracranial aneurysms and arteriovenous 
malformations.
3  A filling defect throughout the left transverse 
and sigmoid sinuses can be seen on the digital 
subtraction angiogram, which is suggestive of 
venous sinus thrombosis.
4  The treatment for venous sinus thrombosis 
is anticoagulation with heparin and 
subsequently warfarin.
CASE REPORT
Orthopnoea in a young woman
1  Respiratory muscle weakness causing nocturnal hypoventilation and cor pulmonale. 
Overnight oximetry showed precipitous desaturation associated with reflex tachycardia 
on lying flat, suggestive of respiratory muscle weakness. This is supported by the history 
of orthopnoea and previous episode of type 2 respiratory failure.
2  First line investigations are: lung function tests (spirometry, lung volumes, and gas 
transfer); lying, sitting, and standing spirometry; maximal inspiratory mouth pressures 
and sniff nasal inspiratory pressures. Other investigations include measurement of 
transdiaphragmatic pressure and phrenic nerve magnetic stimulation if available.
3  Possible causes are: neural abnormalities (Guillain-Barré syndrome, trauma, mediastinal 
malignancies, herpes zoster, motor neurone disease, vasculitis, hereditary sensorimotor 
polyneuropathy, critical illness polyneuropathy, alcoholism, diabetes); disorders of the 
neuromuscular junction (toxins, drugs, myasthenia gravis); and abnormalities of muscle 
tissue (muscular dystrophies, myopathies, acid maltase deficiency, hypothyroidism, 
systemic lupus erythematosis, mechanical ventilation induced diaphragmatic 
dysfunction).
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